Mayacaman
08-06-2020, 09:05 AM
White Paper on Hydroxychloroquine
View the PDF (https://drive.google.com/file/d/1-gsn_Ye2EYDDkV_79Ag1tgUqZLNCMSt-/view)
This is the culmination of months-long research from all sources. It explains how Americans have come to be in the grip of fear. All the myths and all the misconceptions about a safe, generic drug that has been FDA approved for 65 years, given to pregnant women, breastfeeding women, children, the elderly and the immune-compromised for years and decades without complication, are finally put in the trash heap where they belong. You will have the indisputable proof that you have been massively lied to, often very intentionally. At first you will first be heartbroken. And then you will be furious. Good. Because then you will demand change.
Compendium of HCQ Studies
View the PDF (https://drive.google.com/file/d/1l6y3L_KGb1ilMW0FaP4VZsd7WvX2IU3z/view)
The safety of HCQ is irrefutable. The evidence supporting HCQ efficacy against Covid-19 is also overwhelming. All negative HCQ studies have used either: too much, used it alone (it needs Zinc), or used it late (it should be early.) The treatment dose is 200 mg HCQ twice a day for five days + Zinc 50 (elemental) daily. The prophylactic dose is 400 mg HCQ weekly + Zinc 50 (elemental) daily. (There are studies right now to see if HCQ 200 mg. weekly is sufficient.) This is very low dose. (The usual dose of HCQ in Lupus, Rheumatoid Arthritis is 400 mg. daily for years.) There are telemedicine physicians who are aware of the facts and if you are concerned about this, please see one. It is also over the counter in many places in the world including Indonesia and most of South America.
<style> <!-- /* Font Definitions */ @font-face {font-family:Times; panose-1:2 0 5 0 0 0 0 0 0 0; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:3 0 0 0 1 0;} @font-face {font-family:Calibri; panose-1:0 0 0 0 0 0 0 0 0 0; mso-font-alt:Arial; mso-font-charset:77; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;} @font-face {font-family:Cambria; panose-1:0 0 0 0 0 0 0 0 0 0; mso-font-alt:"Times New Roman"; mso-font-charset:77; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-parent:""; margin-top:0in; margin-right:0in; margin-bottom:10.0pt; margin-left:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Cambria; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} h4 {mso-style-link:"Heading 4 Char"; mso-style-next:Normal; margin-top:10.0pt; margin-right:0in; margin-bottom:0in; margin-left:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan lines-together; page-break-after:avoid; mso-outline-level:4; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; font-weight:bold; font-style:italic;} a:link, span.MsoHyperlink {color:blue; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; color:purple; text-decoration:underline; text-underline:single;} p {margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Times; mso-fareast-font-family:Cambria; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Times; mso-bidi-font-family:"Times New Roman";} span.Heading4Char {mso-style-name:"Heading 4 Char"; mso-style-locked:yes; mso-style-link:"Heading 4"; font-family:Calibri; mso-ascii-font-family:Calibri; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; font-weight:bold; font-style:italic;}size:8.5in 11.0in; margin:1.0in 1.25in 1.0in 1.25in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;}</style>
View the PDF (https://drive.google.com/file/d/1-gsn_Ye2EYDDkV_79Ag1tgUqZLNCMSt-/view)
This is the culmination of months-long research from all sources. It explains how Americans have come to be in the grip of fear. All the myths and all the misconceptions about a safe, generic drug that has been FDA approved for 65 years, given to pregnant women, breastfeeding women, children, the elderly and the immune-compromised for years and decades without complication, are finally put in the trash heap where they belong. You will have the indisputable proof that you have been massively lied to, often very intentionally. At first you will first be heartbroken. And then you will be furious. Good. Because then you will demand change.
Compendium of HCQ Studies
View the PDF (https://drive.google.com/file/d/1l6y3L_KGb1ilMW0FaP4VZsd7WvX2IU3z/view)
The safety of HCQ is irrefutable. The evidence supporting HCQ efficacy against Covid-19 is also overwhelming. All negative HCQ studies have used either: too much, used it alone (it needs Zinc), or used it late (it should be early.) The treatment dose is 200 mg HCQ twice a day for five days + Zinc 50 (elemental) daily. The prophylactic dose is 400 mg HCQ weekly + Zinc 50 (elemental) daily. (There are studies right now to see if HCQ 200 mg. weekly is sufficient.) This is very low dose. (The usual dose of HCQ in Lupus, Rheumatoid Arthritis is 400 mg. daily for years.) There are telemedicine physicians who are aware of the facts and if you are concerned about this, please see one. It is also over the counter in many places in the world including Indonesia and most of South America.
<style> <!-- /* Font Definitions */ @font-face {font-family:Times; panose-1:2 0 5 0 0 0 0 0 0 0; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:3 0 0 0 1 0;} @font-face {font-family:Calibri; panose-1:0 0 0 0 0 0 0 0 0 0; mso-font-alt:Arial; mso-font-charset:77; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;} @font-face {font-family:Cambria; panose-1:0 0 0 0 0 0 0 0 0 0; mso-font-alt:"Times New Roman"; mso-font-charset:77; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-parent:""; margin-top:0in; margin-right:0in; margin-bottom:10.0pt; margin-left:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Cambria; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} h4 {mso-style-link:"Heading 4 Char"; mso-style-next:Normal; margin-top:10.0pt; margin-right:0in; margin-bottom:0in; margin-left:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan lines-together; page-break-after:avoid; mso-outline-level:4; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; font-weight:bold; font-style:italic;} a:link, span.MsoHyperlink {color:blue; text-decoration:underline; text-underline:single;} a:visited, span.MsoHyperlinkFollowed {mso-style-noshow:yes; color:purple; text-decoration:underline; text-underline:single;} p {margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Times; mso-fareast-font-family:Cambria; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Times; mso-bidi-font-family:"Times New Roman";} span.Heading4Char {mso-style-name:"Heading 4 Char"; mso-style-locked:yes; mso-style-link:"Heading 4"; font-family:Calibri; mso-ascii-font-family:Calibri; mso-ascii-theme-font:major-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:major-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:major-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi; color:#4F81BD; font-weight:bold; font-style:italic;}size:8.5in 11.0in; margin:1.0in 1.25in 1.0in 1.25in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;}</style>